Endobloc T Kit
Pulmonary Arterial Hypertension
5mg + 20mg
Lower pulmonary artery pressure and improve exercise capacity in pulmonary arterial hypertension
From$17.25/ tabletView
Ambrisentan
Ambrisentan is an endothelin receptor antagonist used for pulmonary arterial hypertension. It blocks endothelin, a substance that narrows blood vessels. The attached catalogue represents ambrisentan both alone in Letairis and with tadalafil in Endobloc T Kit.
Key points
- Ambrisentan belongs to the endothelin receptor antagonist class.
- It is used alone or with tadalafil for pulmonary arterial hypertension.
- Letairis is the attached single-ingredient 5 mg tablet.
- Endobloc T Kit contains 5 mg ambrisentan with 20 mg tadalafil.
Letairis
Letairis contains ambrisentan alone and connects with pulmonary arterial hypertension in the heart and blood pressure category. The official label confirms Letairis as an ambrisentan tablet, supporting the brand-to-ingredient identity.
Blocking endothelin reduces a signal that constricts pulmonary blood vessels. This mechanism explains the ingredient’s place in PAH care.
Endobloc T Kit
Endobloc T Kit combines ambrisentan with tadalafil. Ambrisentan acts through endothelin receptors, while tadalafil is a PDE5 inhibitor with a separate pulmonary vascular mechanism. The two-ingredient record therefore remains visibly distinct from Letairis.
Ambrisentan carries a serious pregnancy warning because it can cause birth defects. Both authority sources make pregnancy testing and prevention requirements central to its safe-use information.